26. January 2015

R&D Milestones Reached

At the beginning of January, two major milestones of one of our internal R&D projects were reached. In our search for new preserving agents we both succeeded in identifying three new, more active compounds and, on the other hand, we could prove their low toxicity in vitro.

Both aspects are of tremendous importance as we are aiming at applications in ophthalmic and other topical APIs. The currently used preserving excipients either do not exhibit a broad antibiotic activity profile (against fungi & microbes) or they show side effects which can not be neglected, especially with longer treatment schemes.

These results back our confidence to finally offer effective and benign alternatives in this important field within the next 1-2 years.

contact us

Cookie Setting: We use Cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our coporate commercial objectives, as well as other cookies which are used soley for anonymous statistical purposes, for more comfortable website settings, or for the display of personal content. You are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. You can always opt-out of our cookie settings. Further information can be found in our data policy.